Gastric acid control: The role of proton pump inhibitors in the treatment of gastroesophageal reflux disease (GERD)

Gastric acid control: The role of proton pump inhibitors in the treatment of gastroesophageal reflux disease (GERD)

Gastroenterology And Hepatology
A badge with ribbon in color black Point(s): 1 | An analog clock in color black 20 minutes | A black calendar with white triangle in center that has a black exclamation point in the middle 27 Oct 2021 

Overview

NEW!

MPS Code: 0569/2020

GERD is a condition wherein stomach acid rises and enters the oesophagus, often resulting in either manageable symptoms or long-term complications if left untreated. Epidemiological studies in Asia have shown an increasing prevalence of symptom-based GERD year after year. This module aims to educate healthcare providers on the use of proton pump inhibitors (PPIs) as an effective treatment in suppressing gastric acid secretion in patients with GERD. Compared to other methods of treatment, PPIs exhibit faster onset of action with tolerable safety profiles.

Who should participate:
Pharmacists

NOTE :
Please read thoroughly & understand the module before attempting the assessment questions.

Terms & Conditions: 
 Participants must obtain a minimum score of 7/10 (70%) to be awarded 1 point.
■ MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD points.

The modules/articles are best viewed with:
Google Chrome, Firefox, Internet Explorer, Safari or any other W3C standards-compliant browser may be required to view the modules.  

Sponsored by:

Eisai_logo.jpg